 |
9 Products |  |
120 Diseases | | 9 Products |
|
46 Trials |  |
2133 News |  |
| «12...18192021222324252627282930 |
- ||||| Natesto (testosterone) / Acerus, Medac, Aytu BioPharma
Enrollment closed: Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism (clinicaltrials.gov) - Jun 12, 2012
P3, N=280, Active, not recruiting, Sponsor: Trimel Biopharma SRL
Recruiting --> Active, not recruiting
- Natesto (testosterone) / Acerus, Medac, Aytu BioPharma
Trial withdrawal: Influence of Administration Route of Testosterone on Male Fertility (clinicaltrials.gov) - May 2, 2012
P1, N=0, Withdrawn, Sponsor: M et P Pharma
Recruiting --> Active, not recruiting Not yet recruiting --> Withdrawn
- Natesto (testosterone) / Acerus, Medac, Aytu BioPharma
Enrollment change: Influence of Administration Route of Testosterone on Male Fertility (clinicaltrials.gov) - May 2, 2012
P1, N=0, Withdrawn, Sponsor: M et P Pharma
Not yet recruiting --> Withdrawn N=20 --> 0
- ||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen, Oncaspar liquid (pegaspargase) / Servier, lestaurtinib (CEP-701) / Teva, Kyowa Kirin
Clinical: Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (clinicaltrials.gov) - May 2, 2012
P3, N=315, Recruiting, Sponsor: Children's Oncology Group
N=20 --> 0 N=244 --> 315
- | Natesto (testosterone) / Acerus, Medac, Aytu BioPharma
Enrollment change: NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers (clinicaltrials.gov) - May 1, 2012
P2, N=32, Completed, Sponsor: M et P Pharma
N=244 --> 315 N=16 --> 32
- | Natesto (testosterone) / Acerus, Medac, Aytu BioPharma
Trial completion: NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers (clinicaltrials.gov) - May 1, 2012
P2, N=32, Completed, Sponsor: M et P Pharma
N=16 --> 32 Recruiting --> Completed
- | Ovastat (treosulfan) / Medac, Medexus, Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
New P2 trial: Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning (clinicaltrials.gov) - Apr 15, 2012
P2, N=60, Recruiting, Sponsor: Wolfgang Bethge, MD
- Ovastat (treosulfan) / Medac, Medexus
Enrollment closed: Treosulfan-based Conditioning for Transplantation in AML/MDS (clinicaltrials.gov) - Jan 23, 2012
P2, N=24, Active, not recruiting, Sponsor: Dr. Avichai Shimoni MD
Recruiting --> Completed Recruiting --> Active, not recruiting
- |||||||||| Natesto (testosterone) / Acerus, Medac, Aytu BioPharma
New P3 trial: Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism (clinicaltrials.gov) - Oct 2, 2011
P3, N=280, Active, not recruiting, Sponsor: Trimel Biopharma SRL
- | Ovastat (treosulfan) / Medac, Medexus, Grafalon (rabbit anti-T-lymphocyte globulin) / Mundipharma, NeoPharm
Enrollment closed: ALL-SCT-BFM-2003: Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia (clinicaltrials.gov) - Sep 29, 2011
P3, N=400, Active, not recruiting, Sponsor: St. Anna Kinderkrebsforschung
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | Ovastat (treosulfan) / Medac, Medexus, Grafalon (rabbit anti-T-lymphocyte globulin) / Mundipharma, NeoPharm
Enrollment closed: ALL-SCT-BFMi: ALL-SCT BFM International- HSCT in Children and Adolescents With ALL (clinicaltrials.gov) - Sep 29, 2011
P3, N=405, Active, not recruiting, Sponsor: St. Anna Kinderkrebsforschung
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Ovastat (treosulfan) / Medac, Medexus
Enrollment change: Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Sep 6, 2011
P2, N=96, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Recruiting --> Active, not recruiting N=72 --> 96
- || Ovastat (treosulfan) / Medac, Medexus, Grafalon (rabbit anti-T-lymphocyte globulin) / Mundipharma, NeoPharm
New P3 trial: ALL-SCT-BFM-2003: Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia (clinicaltrials.gov) - Aug 24, 2011
P3, N=400, Active, not recruiting, Sponsor: St. Anna Kinderkrebsforschung
- || Ovastat (treosulfan) / Medac, Medexus, Grafalon (rabbit anti-T-lymphocyte globulin) / Mundipharma, NeoPharm
New P3 trial: ALL-SCT-BFMi: ALL-SCT BFM International- HSCT in Children and Adolescents With ALL (clinicaltrials.gov) - Aug 22, 2011
P3, N=405, Active, not recruiting, Sponsor: St. Anna Kinderkrebsforschung